Last updated: 2026-09-16 06:00:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
DexCom, Inc. (DXCM) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $86.44, with a market capitalisation of $31.33B and a P/E ratio of 31.96. Over the past 52 weeks, its price has ranged from $54.11 to $92.59. This page covers its latest market performance, valuation, price trends and company information.
$31.33B | |
$84.04 | |
$164.86 | |
$0.34 | |
$84.68 | |
3.62M | |
4.67M | |
31.96 | |
$92.59 | |
$54.11 | |
-- | |
-- |
DexCom, Inc. (DXCM) last closed at $84.68 as of 2026-09-15 23:57:00, unchanged from the previous close of $84.68.
During the latest regular trading session, DXCM traded between $0.34 and $164.86, with a volume of 3.62M shares. The closing price was near the middle and near the upper end of its 52-week range.
Over the past seven days, DexCom, Inc. (DXCM) moved from $89.71 to $86.44, representing a decline of 3.65% ($3.27).
The stock traded between $82.29 and $91.00 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 3.58 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 84.0%
DXCM is currently trading at $86.44, placing it 84.0% of the way from its 52-week low of $54.11 to its 52-week high of $92.59. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 11100 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of DexCom, Inc. (DXCM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.